3,3-Dimethylpyrrolidine → HCID 59605690, compound

HRID 1923049Notes

Reaction equation

HRID 1923049 reaction equation
Br[CH2:2][C:3]1[N:4]([CH3:28])[C:5]2[C:10]([N:11]=1)=[C:9]([N:12]1[CH2:17][CH2:16][O:15][CH2:14][CH2:13]1)[N:8]=[C:7]([N:18]1[C:22]3[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=3[N:20]=[C:19]1[CH3:27])[N:6]=2.[CH3:29][C:30]1([CH3:35])[CH2:34][CH2:33][NH:32][CH2:31]1>>[CH3:29][C:30]1([CH3:35])[CH2:34][CH2:33][N:32]([CH2:2][C:3]2[N:4]([CH3:28])[C:5]3[C:10]([N:11]=2)=[C:9]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][CH2:13]2)[N:8]=[C:7]([N:18]2[C:22]4[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=4[N:20]=[C:19]2[CH3:27])[N:6]=3)[CH2:31]1

Participants

3

Reactant 2

HCID 149492113,3-DimethylpyrrolidineHCID 596058124-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine

Product 1

HCID 59605690HCID 59605690, compound

Procedure

4-(8-(Bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine (50 mg) was reacted with 3,3-dimethylpyrrolidine via General Procedure E to give 16.8 mg of 300 following reverse phase purification. MS (Q1) 461.2 (M)+

Workup

  1. customto give
  2. custom16.8 mg of 300 following reverse phase purification

Sources & evidence

ORD record
ord-34844ee9b6d1454580b6cd6315f9832c
Source dataset
uspto-grants-2012_05
Patent number
US08173650B2

Reaction notes

Loading…